Reflections and Major Developments in CLL from ASH 2011

patientpower has 2343 videos Subscribe Here

Description: Dr. Michael Keating, President of the CLL Global Research Foundation, gives an overview--and his very positive perspective--about the landscape for CLL, including research around Chimeric Antigen Receptors (CAR), Tyrosine Kinase Inhibitors (TKIs), genetic mutations and novel agents in trials. Look for in-depth interviews from other CLL Global Alliance researchers on these topics coming soon.
Shared By : patientpower
Posted on : 03/20/12
Added : 6 years ago
Category : Other